390 related articles for article (PubMed ID: 17453877)
1. Physostigmine for gamma-hydroxybutyrate coma: inefficacy, adverse events, and review.
Zvosec DL; Smith SW; Litonjua R; Westfal RE
Clin Toxicol (Phila); 2007; 45(3):261-5. PubMed ID: 17453877
[TBL] [Abstract][Full Text] [Related]
2. Physostigmine does not effect arousal but produces toxicity in an animal model of severe gamma-hydroxybutyrate intoxication.
Bania TC; Chu J
Acad Emerg Med; 2005 Mar; 12(3):185-9. PubMed ID: 15741579
[TBL] [Abstract][Full Text] [Related]
3. Gamma-hydroxybutyrate overdose and physostigmine: teaching new tricks to an old drug?
Caldicott DG; Kuhn M
Ann Emerg Med; 2001 Jan; 37(1):99-102. PubMed ID: 11145779
[TBL] [Abstract][Full Text] [Related]
4. Abrupt awakening phenomenon associated with gamma-hydroxybutyrate use: a case series.
Van Sassenbroeck DK; De Neve N; De Paepe P; Belpaire FM; Verstraete AG; Calle PA; Buylaert WA
Clin Toxicol (Phila); 2007; 45(5):533-8. PubMed ID: 17503262
[TBL] [Abstract][Full Text] [Related]
5. Gamma-hydroxybutyrate (GHB): a new drug of misuse.
Williams H; Taylor R; Roberts M
Ir Med J; 1998; 91(2):56-7. PubMed ID: 9617031
[TBL] [Abstract][Full Text] [Related]
6. Clinical course of gamma-hydroxybutyrate overdose.
Chin RL; Sporer KA; Cullison B; Dyer JE; Wu TD
Ann Emerg Med; 1998 Jun; 31(6):716-22. PubMed ID: 9624311
[TBL] [Abstract][Full Text] [Related]
7. [A new drug reaches Switzerland: coma after intake of gamma-hydroxybutyrate (GHB)].
Iten PX; Oestreich A; Lips R; Brabetz M
Schweiz Med Wochenschr; 2000 Mar; 130(10):356-61. PubMed ID: 10763213
[TBL] [Abstract][Full Text] [Related]
8. Case series of 226 γ-hydroxybutyrate-associated deaths: lethal toxicity and trauma.
Zvosec DL; Smith SW; Porrata T; Strobl AQ; Dyer JE
Am J Emerg Med; 2011 Mar; 29(3):319-32. PubMed ID: 20825811
[TBL] [Abstract][Full Text] [Related]
9. Clinical features of gamma-hydroxybutyrate and gamma-butyrolactone toxicity and concomitant drug and alcohol use.
Liechti ME; Kunz I; Greminger P; Speich R; Kupferschmidt H
Drug Alcohol Depend; 2006 Feb; 81(3):323-6. PubMed ID: 16143455
[TBL] [Abstract][Full Text] [Related]
10. Hospital in the field: prehospital management of GHB intoxication by medical assistance teams.
Dutch MJ; Austin KB
Prehosp Disaster Med; 2012 Oct; 27(5):463-7. PubMed ID: 22809488
[TBL] [Abstract][Full Text] [Related]
11. [Sudden coma in a 20-year-old man].
Herbrand R; Greminger P; Schurter G; Pletscher W; Kupferschmidt H
Praxis (Bern 1994); 2000 Aug; 89(34):1326-30. PubMed ID: 11021186
[TBL] [Abstract][Full Text] [Related]
12. Reply to "Insufficient evidence that agitation is common in gamma-hydroxybutyrate (GHB) toxicity," submitted in response to our original article entitled, "Agitation is common in gamma-hydroxybutyrate toxicity," published in AJEM, May 2005.
Zvosec DL; Smith SW
Am J Emerg Med; 2006 May; 24(3):388-9. PubMed ID: 16635731
[No Abstract] [Full Text] [Related]
13. [Gamma-hydroxybutyrate, a new central nervous system stimulant].
Strange DG; Jensen D
Ugeskr Laeger; 1999 Dec; 161(50):6934-6. PubMed ID: 10643381
[TBL] [Abstract][Full Text] [Related]
14. A tale of novel intoxication: a review of the effects of gamma-hydroxybutyric acid with recommendations for management.
Li J; Stokes SA; Woeckener A
Ann Emerg Med; 1998 Jun; 31(6):729-36. PubMed ID: 9624313
[TBL] [Abstract][Full Text] [Related]
15. Medical and legal confusion surrounding gamma-hydroxybutyrate (GHB) and its precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4BD).
Wood DM; Warren-Gash C; Ashraf T; Greene SL; Shather Z; Trivedy C; Clarke S; Ramsey J; Holt DW; Dargan PI
QJM; 2008 Jan; 101(1):23-9. PubMed ID: 18203723
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcomes in children with hyoscyamus niger intoxication not receiving physostigmine therapy.
Doneray H; Orbak Z; Karakelleoglu C
Eur J Emerg Med; 2007 Dec; 14(6):348-50. PubMed ID: 17968201
[TBL] [Abstract][Full Text] [Related]
17. [Gamma-hydroxybutyrate--an endogenous substance and a new central nervous system stimulant. Clinical aspects of acute poisoning].
Engelsen J; Christensen HR
Ugeskr Laeger; 1999 Dec; 161(50):6903-7. PubMed ID: 10643375
[TBL] [Abstract][Full Text] [Related]
18. Presentations to an urban emergency department in Switzerland due to acute γ-hydroxybutyrate toxicity.
Liakoni E; Walther F; Nickel CH; Liechti ME
Scand J Trauma Resusc Emerg Med; 2016 Aug; 24(1):107. PubMed ID: 27581664
[TBL] [Abstract][Full Text] [Related]
19. Reversal of quetiapine-induced altered mental status with physostigmine: a case series.
Cole JB; Stellpflug SJ; Ellsworth H; Harris CR
Am J Emerg Med; 2012 Jul; 30(6):950-3. PubMed ID: 21802878
[TBL] [Abstract][Full Text] [Related]
20. Physostigmine as a treatment for gamma-hydroxybutyrate toxicity: a review.
Traub SJ; Nelson LS; Hoffman RS
J Toxicol Clin Toxicol; 2002; 40(6):781-7. PubMed ID: 12475191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
